Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer

2021 ◽  
Author(s):  
Filipa Lynce ◽  
James T. Williams ◽  
Meredith M. Regan ◽  
Craig A. Bunnell ◽  
Rachel A. Freedman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Metastatic Breast ◽  
Weekly Paclitaxel

scholarly journals A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer

2011 ◽  
Vol 22 (12) ◽  
pp. 2575-2581 ◽  
Author(s):  
M.N. Fornier ◽  
P.G. Morris ◽  
A. Abbruzzi ◽  
G. D'Andrea ◽  
T. Gilewski ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Metastatic Breast ◽  
Weekly Paclitaxel

Combination of tivozanib (AV-951) with weekly paclitaxel for metastatic breast cancer: Results of a phase I study.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 1092-1092 ◽  
Author(s):  
E. L. Mayer ◽  
M. E. Scheulen ◽  
J. Beckman ◽  
H. Richly ◽  
A. Poli ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Metastatic Breast ◽  
Weekly Paclitaxel

scholarly journals A Phase I Study of Pemetrexed (ALIMTA) and Cyclophosphamide in Patients with Locally Advanced or Metastatic Breast Cancer

2006 ◽  
Vol 12 (23) ◽  
pp. 7071-7078 ◽  
Author(s):  
Christian Dittrich ◽  
Lubos Petruzelka ◽  
Pavel Vodvarka ◽  
Margit Gneist ◽  
Filip Janku ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Locally Advanced ◽  
Metastatic Breast

scholarly journals Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

2016 ◽  
Vol 16 (2) ◽  
pp. 82-86 ◽  
Author(s):  
Winston W. Tan ◽  
Jacob B. Allred ◽  
Alvaro Moreno-Aspitia ◽  
Donald W. Northfelt ◽  
James N. Ingle ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Phase I Study ◽  
Metastatic Breast ◽  
Breast Cancer Patients

scholarly journals Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes

2012 ◽  
Vol 70 (1) ◽  
pp. 49-56 ◽  
Author(s):  
Maryam B. Lustberg ◽  
Shubham Pant ◽  
Amy S. Ruppert ◽  
Tong Shen ◽  
Yong Wei ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Weekly Paclitaxel

Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial

2008 ◽  
Vol 63 (5) ◽  
pp. 953-958 ◽  
Author(s):  
Sibylle Loibl ◽  
Caroline Murmann ◽  
Katrin Schwedler ◽  
Mathias Warm ◽  
Lothar Müller ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Dose Finding ◽  
Weekly Paclitaxel ◽  
Finding Study ◽  
Dose Finding Study

scholarly journals A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

2009 ◽  
Vol 119 (3) ◽  
pp. 673-683 ◽  
Author(s):  
Ursula Wiedermann ◽  
C. Wiltschke ◽  
J. Jasinska ◽  
M. Kundi ◽  
R. Zurbriggen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Immune Responses ◽  
Phase I ◽  
Phase I Study ◽  
Peptide Vaccine ◽  
Metastatic Breast ◽  
Her 2
Sign in / Sign up

Export Citation Format

Share Document